Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer-Reference-Cited by-同舟云学术

Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer

Published:2021-11-11 Issue:1 Volume:15 Page:55-62
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Gomez‐Roca Carlos¹,Even Caroline²,Le Tourneau Christophe³,Basté Neus²,Delord Jean‐Pierre¹,Sarini Jerome⁴,Vergez Sebastien⁴,Temam Stephane²,Hoffmann Caroline³,Rochaix Philippe⁵,Borcoman Edith³,Gavillet Bruno⁶,Rouits Elisabeth⁶,Ménétrey Annick⁶,Brichory Franck⁶,Purcea Daniela⁶,Vuagniaux Gregoire⁶,Zanna Claudio⁶

Affiliation:

1. Clinical Research Unit Institut Universitaire du Cancer de Toulouse‐Oncopole Toulouse France

2. Institut Gustave‐Roussy Villejuif France

3. Department of Drug Development and Innovation (D3i) Institut Curie Paris and Saint‐Cloud France

4. Surgery Department Institut Universitaire du Cancer de Toulouse‐Oncopole Toulouse France

5. Pathology Department Institut Universitaire du Cancer de Toulouse‐Oncopole Toulouse France

6. Debiopharm International S.A Lausanne Switzerland

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13002

Reference13 articles.

1. Hallmarks of Cancer: The Next Generation

2. IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer

3. Targeting IAP proteins for therapeutic intervention in cancer

4. Comprehensive genomic characterization of head and neck squamous cell carcinomas

5. XIAP Is a Predictor of Cisplatin-Based Chemotherapy Response and Prognosis for Patients with Advanced Head and Neck Cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck;Cancer Treatment Reviews;2024-09

2. Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial;Clinical Cancer Research;2024-03-19

3. Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design;Future Oncology;2024-01-10

4. Letter to the Editor: SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses;Cellular Immunology;2024-01

5. Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect;Journal of Translational Medicine;2023-11-06